FBIO (Fortress Biotech) FCF Margin %: 1,271.05% (As of Mar. 2026)

What is Fortress Biotech FCF Margin %?

Fortress Biotech FBIO -1.26% 44 FCF Margin % is 1,271.05% as of Mar. 2026. GuruFocus rates FBIO with a GF Score™ of 44/100 and a GF Value™ of $1.23 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 959 Biotechnology companies, Fortress Biotech ranks better than 99.48% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Fortress Biotech's Free Cash Flow for the three months ended in Mar. 2026 was $203.85 Mil. Fortress Biotech's Revenue for the three months ended in Mar. 2026 was $16.04 Mil. Therefore, Fortress Biotech's FCF Margin % for the quarter that ended in Mar. 2026 was 1,271.05%.

As of today, Fortress Biotech's current FCF Yield % is 151.12%.

The historical rank and industry rank for Fortress Biotech's FCF Margin % or its related term are showing as below:

FBIO' s FCF Margin % Range Over the Past 10 Years
Min: -494.74 Med: -220.06 Max: 238.26
Current: 238.26

During the past 13 years, the highest FCF Margin % of Fortress Biotech was 238.26%. The lowest was -494.74%. And the median was -220.06%.

FBIO's FCF Margin % is ranked better than
99.48% of 959 companies
in the Biotechnology industry
Industry Median: -84.65 vs FBIO: 238.26

Fortress Biotech FCF Margin % Related Terms

Fortress Biotech FCF Margin % Historical Data

* Premium members only.

The historical data trend for Fortress Biotech's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fortress Biotech FCF Margin % Chart

Fortress Biotech Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

FCF Margin %

Get a 7-Day Free Trial

-193.17

-240.89

-161.30

-165.05

-103.98

Fortress Biotech Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
FCF Margin %	Get a 7-Day Free Trial															-148.89	-167.92	-34.65	-78.01	1,271.05

FBIO vs PTHS, IBIO, NRXS: FCF Margin % Comparison

For the Biotechnology subindustry, Fortress Biotech's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fortress Biotech FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Fortress Biotech's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Fortress Biotech's FCF Margin % falls into.

Save Embed

44GF Score

Fortress Biotech Inc FBIO

FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Fortress Biotech FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Fortress Biotech's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-65.777	/	63.262
	=	-103.98 %

Fortress Biotech's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	203.851	/	16.038
	=	1,271.05 %

Frequently Asked Questions Learn more about FCF Margin % →

What does a FCF Margin % of 1,271.05% mean?

Fortress Biotech (FBIO) has a FCF Margin % of 1,271.05% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Fortress Biotech and its competitors. According to the industry distribution chart, Fortress Biotech ranks #5 out of 959 companies in the Biotechnology industry, placing it in the top 0.5%.

Is Fortress Biotech's FCF Margin % too high?

Fortress Biotech's current FCF Margin % is 1,271.05%. Based on the distribution chart, Fortress Biotech ranks #5 out of 959 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Fortress Biotech has a GF Score™ of 44/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Fortress Biotech's FCF Margin % compare to PTHS and IBIO?

According to the Biotechnology industry distribution chart, Fortress Biotech ranks #5 out of 959 companies for FCF Margin %. This places Fortress Biotech in the top 1% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good FCF Margin % for a Biotechnology company?

A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high FCF Margin % mean?

A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Fortress Biotech and its competitors. Fortress Biotech's current FCF Margin % is 1,271.05%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Fortress Biotech stock overvalued right now?

Based on GuruFocus' analysis, Fortress Biotech (FBIO) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.23, compared to a current price of $3.14 — trading 155.3% above its estimated fair value. The current FCF Margin % is 1,271.05%. Fortress Biotech's overall GF Score™ is 44/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is FCF Margin % calculated?

FCF Margin % is calculated from a company's financial statements. For Fortress Biotech (FBIO), the current FCF Margin % is 1,271.05% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fortress Biotech (FBIO) Overvalued in 2026?

Based on GuruFocus' analysis, Fortress Biotech stock appears to be overvalued. The current stock price of $3.14 is trading 155.3% above its estimated GF Value™ of $1.23. GuruFocus considers Fortress Biotech to be Significantly Overvalued.

Key valuation signals for FBIO:

FCF Margin %: 1,271.05%
GF Value™: $1.23 vs. price of $3.14 (155.3% above fair value)
GF Score™: 44/100 with 7 warning signs

No single metric tells the full story. See the FBIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fortress Biotech Business Description

Industry Healthcare Biotechnology

Comparable Companies PTHS IBIO NRXS ATRA ICCC RNTX OSTX LONA PYPD ANIX VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Other Exchanges FBIOP.PFD:USA CNB0.PFD:Germany

Address 1111 Kane Concourse, Suite 301, Bay Harbor Island, FL, USA, 33154

Website https://www.fortressbiotech.com

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.

44GF Score

Get the complete analysis for FBIO

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.14

Price

$1.23

GF Value

View FBIO Analysis

See FCF Margin % data for all stocks →